Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)?

Lupus

Volumn 9, Issue 7, 2000, Pages 561-562

  Malaviya, A N ^a   Mourou, M ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MUBARAK AL KABEER HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PHOSPHOLIPID ANTIBODY;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; LETTER; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CORONARY DISEASE; HUMANS; HYPERTENSION; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0033818745     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120330000900717     Document Type: Letter

References (21)

1. Hydroxychloroquine: Past, present, future
2. Aspects of use of antimalarials in systemic lupus erythematosus
3. The primary prevention of coronary heart disease in women
4. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Cause of death
5. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with Framingham study
6. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus
7. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus
8. British Hypertension Society guidelines for hypertension management 1999: Summary
9. 'Primary', 'secondary', 'catastrophic', and other variants of the antiphospholipid syndrome
10. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome
11. Lupus pregnancy loss and antiphospholipid antibodies
12. Risk factors for osteonecrosis in systemic lupus erythematosus
13. Pattern of neuropsychologic dysfunction in active systemic lupus erythematosus
14. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study
15. Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: Case-control study
16. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary embolism prevention (PEP) trial
17. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome
18. Prednisone and aspirin in women with autoantibodies and unexplained recurrent foetal loss
19. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease
20. Systemic lupus erythematosus, berry aneurysm and subarachnoid haemorrhage
21. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies